XML 54 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Mar. 31, 2023
Income Taxes [Abstract]  
Earnings (Loss) Before Income Taxes
 
Years ended March 31,
 
   
2023
   
2022
   
2021
 
Components of earnings (loss) before income taxes:
                 
United States
 
$
12.5
   
$
0.4
   
$
(48.7
)
Foreign
   
112.8
     
101.1
     
(70.6
)
Total earnings (loss) before income taxes
 
$
125.3
   
$
101.5
   
$
(119.3
)
Income Tax (Benefit) Provision

Income tax (benefit) provision:
                 
Federal:
                 
Current
 
$
1.5
   
$
0.1
   
$
(0.1
)
Deferred
   
(47.5
)
   
-
     
58.3
 
State:
                       
Current
   
2.3
     
1.1
     
0.4
 
Deferred
   
(11.4
)
   
-
     
9.2
 
Foreign:
                       
Current
   
27.5
     
17.8
     
22.0
 
Deferred
   
(0.7
)
   
(3.8
)
   
0.4
 
Total income tax (benefit) provision
 
$
(28.3
)
 
$
15.2
   
$
90.2
 
Reconciliation of U.S. Federal Statutory Rate to Effective Tax Rate
The reconciliation between the U.S. federal statutory rate and the Company’s effective tax rate was as follows:

 
Years ended March 31,
 
   
2023
   
2022
   
2021
 
Statutory federal tax
    21.0 %     21.0 %     21.0 %
State taxes, net of federal benefit
    (0.1 )     1.4     0.9
Taxes on non-U.S. earnings and losses
    5.8     3.5     (9.1 )
Valuation allowances
    (42.9 )     (8.8 )     (92.9 )
Tax credits
    (4.5 )     (3.4 )     2.2
Compensation
    0.7     0.6     (1.3 )
Tax rate or law changes
    (0.2 )     0.6     (0.2 )
Uncertain tax positions, net of settlements
    0.4     (0.2 )     0.1
Notional interest deductions
    (1.7 )     (2.7 )     1.3
Dividends and taxable foreign inclusions
    0.9     1.6     3.0
Other
    (2.0 )     1.4     (0.6 )
Effective tax rate
    (22.6 %)     15.0 %     (75.6 %)
Deferred Tax Assets and Liabilities
The tax effects of temporary differences that gave rise to deferred tax assets and liabilities were as follows:

 
March 31,
 
   
2023
   
2022
 
Deferred tax assets:
           
Accounts receivable
 
$
0.9
   
$
0.8
 
Inventories
   
6.0
     
6.5
 
Plant and equipment
   
17.2
     
19.9
 
Lease liabilities
   
15.9
     
13.5
 
Pension and employee benefits
   
24.1
     
27.5
 
Net operating and capital losses
   
55.4
     
53.9
 
Credit carryforwards
   
49.0
     
48.5
 
Research and experimental expenditures
    8.0       -  
Other, principally accrued liabilities
   
13.2
     
13.5
 
Total gross deferred tax assets
   
189.7
     
184.1
 
Less: valuation allowances
   
(61.6
)
   
(112.2
)
Net deferred tax assets
   
128.1
     
71.9
 
                 
Deferred tax liabilities:
               
Plant and equipment
   
7.5
     
8.6
 
Lease assets
   
15.7
     
13.2
 
Goodwill
   
4.8
     
4.9
 
Intangible assets
   
20.1
     
22.4
 
Other
   
1.1
     
1.5
 
Total gross deferred tax liabilities
   
49.2
     
50.6
 
Net deferred tax assets
 
$
78.9
   
$
21.3
 
Unrecognized Tax Benefits

Unrecognized tax benefits were as follows:

 
Years ended March 31,
 
   
2023
   
2022
 
Beginning balance
 
$
9.3
   
$
9.6
 
Gross increases - tax positions in prior period
   
0.2
     
0.1
 
Gross decreases - tax positions in prior period
   
(0.1
)
   
(0.2
)
Gross increases - tax positions in current period
   
0.9
     
1.0
 
Lapse of statute of limitations
   
(0.6
)
   
(1.2
)
Ending balance
 
$
9.7
   
$
9.3
 
Tax Years Subject to Examination
The Company files income tax returns in multiple jurisdictions and is subject to examination by taxing authorities throughout the world. At March 31, 2023, the Company was under income tax examination in a number of jurisdictions. The following tax years remain subject to examination for the Company’s major tax jurisdictions:

Germany
Fiscal 2017 - Fiscal 2022
Italy
Fiscal 2018 - Fiscal 2022
United States
Fiscal 2020 - Fiscal 2022